These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
870 related items for PubMed ID: 7477219
1. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. Køber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J, Cole DS, Auclert L, Pauly NC. N Engl J Med; 1995 Dec 21; 333(25):1670-6. PubMed ID: 7477219 [Abstract] [Full Text] [Related]
2. [Trandolapril in patients with left ventricular insufficiency after myocardial infarction]. Aliot E. Arch Mal Coeur Vaiss; 1996 Aug 21; 89 Spec No 3():23-31. PubMed ID: 8949315 [Abstract] [Full Text] [Related]
3. [The significance of trandelapril for mortality after AMI in patients with reduced left ventricular function. TRACE Study Group]. Køber L, Torp-Pedersen CT, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbaek J. Ugeskr Laeger; 1997 Mar 10; 159(11):1616-22. PubMed ID: 9092145 [Abstract] [Full Text] [Related]
4. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. Ambrosioni E, Borghi C, Magnani B. N Engl J Med; 1995 Jan 12; 332(2):80-5. PubMed ID: 7990904 [Abstract] [Full Text] [Related]
5. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years. Buch P, Rasmussen S, Abildstrom SZ, Køber L, Carlsen J, Torp-Pedersen C, TRACE investigators. Eur Heart J; 2005 Jan 12; 26(2):145-52. PubMed ID: 15618070 [Abstract] [Full Text] [Related]
6. Influence of a history of arterial hypertension and pretreatment blood pressure on the effect of angiotensin converting enzyme inhibition after acute myocardial infarction. Trandolapril Cardiac Evaluation Study. Gustafsson F, Køber L, Torp-Pedersen C, Per Hildebrandt. J Hypertens Suppl; 1998 Jan 12; 16(1):S65-70. PubMed ID: 9534100 [Abstract] [Full Text] [Related]
7. Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study. Torp-Pedersen C, Køber L, Carlsen J. Am Heart J; 1996 Jul 12; 132(1 Pt 2 Su):235-43. PubMed ID: 8677862 [Abstract] [Full Text] [Related]
8. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA, Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. N Engl J Med; 2005 Jun 23; 352(25):2581-8. PubMed ID: 15972864 [Abstract] [Full Text] [Related]
9. [Trandolapril in the prevention of the sequelae of left ventricular systolic dysfunction after acute myocardial infarct]. Buksa M. Med Arh; 2000 Jun 23; 54(2):103-6. PubMed ID: 10934839 [Abstract] [Full Text] [Related]
15. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG. Eur Heart J; 1997 Jan 23; 18(1):41-51. PubMed ID: 9049514 [Abstract] [Full Text] [Related]